Article Details

Biocytogen Enters into RenMab(TM)/RenLite(TM) Licensing Agreement with Xencor

Retrieved on: 2020-12-07 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Biocytogen Enters into RenMab(TM)/RenLite(TM) Licensing Agreement with Xencor. View article details on hiswai:

Excerpt

The leading platform for fully human antibody generation ... company developing engineered <b>monoclonal antibodies</b> for the treatment of cancer and ...

Article found on: homenewshere.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo